A hearing on the relief Fortnite maker Epic Games is entitled to in its successful competition case against Google and Apple could be affected by a hearing on a worldwide settlement reached by Google, a judge has said.
Orders proposed by Apple after a judge’s finding that the digital giant and rival Google engaged in anti-competitive conduct would “rob the court’s findings of their detail, their efficacy and their bite”, Epic Games has said.
In the wake of a judgment that Apple and Google misused their market power in running their app stores, the tech giants are fighting injunctions proposed by Epic Games, which they say go beyond the case argued at trial.
A judge has put off deciding what damages group members are owed in two class actions against Apple and Google after finding the tech companies engaged in anti-competitive conduct in the app marketplace.
In a major win for two class actions and Fortnite maker Epic Games, a judge has found that Apple and Google misused their market power in running app stores and in-app purchase systems.
Google has slammed Fortnite game maker Epic Games’ landmark competition case against it as “contrary to commercial reality”, saying its competition with rival tech giant Apple means it is no monopolist.
In a landmark competition case, Apple has told the Federal Court that Epic Games and other developers should not be allowed to “freeride” on the resources and user base the tech giant has “spent many billions” to develop.
Epic Games has taken aim at Google for the “untruthful evidence” of its witnesses in the game maker’s competition case against the tech giant, as well as its failure to call senior executives to the stand to defend itself.
Video game maker Epic Games has attacked as “entirely contrived” the defence by Apple in closing submissions in a Federal Court trial of its landmark competition case, pointing to the tech giant’s lack of evidence, including from CEO Tim Cook.
A judge has upheld Neurim Pharmaceutical’s claim for additional damages against two generic drug companies found to have infringed its patent for insomnia drug Circadin, despite the company’s failure to comply with an earlier ruling.